Latest Insider Transactions at Icu Medical Inc (ICUI)
This section provides a real-time view of insider transactions for Icu Medical Inc (ICUI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ICU MEDICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ICU MEDICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2023
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,129
-5.5%
|
$177,253
$157.47 P/Share
|
|
Mar 07
2023
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,145
+9.46%
|
-
|
|
Mar 07
2023
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,694
-6.98%
|
$265,958
$157.47 P/Share
|
|
Mar 07
2023
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,218
+11.71%
|
-
|
|
Mar 07
2023
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,129
-9.03%
|
$177,253
$157.47 P/Share
|
|
Mar 07
2023
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,145
+14.65%
|
-
|
|
Mar 06
2023
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
839
-18.08%
|
$135,079
$161.25 P/Share
|
|
Mar 06
2023
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,595
+25.58%
|
-
|
|
Mar 06
2023
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
626
-5.92%
|
$100,786
$161.25 P/Share
|
|
Mar 06
2023
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
1,417
+11.82%
|
-
|
|
Mar 06
2023
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,420
-12.47%
|
$872,620
$161.25 P/Share
|
|
Mar 06
2023
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,296
+17.84%
|
-
|
|
Mar 06
2023
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,194
-12.71%
|
$997,234
$161.25 P/Share
|
|
Mar 06
2023
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,767
+18.43%
|
-
|
|
Mar 06
2023
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,420
-21.2%
|
$872,620
$161.25 P/Share
|
|
Mar 06
2023
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,296
+27.49%
|
-
|
|
Feb 02
2023
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Open market or private sale
|
Direct |
1,731
-15.91%
|
$346,200
$200.0 P/Share
|
|
Nov 15
2022
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Open market or private sale
|
Direct |
325
-9.64%
|
$52,000
$160.12 P/Share
|
|
Sep 21
2022
|
George A Lopez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
79,576
+18.06%
|
$4,854,136
$61.76 P/Share
|
|
May 23
2022
|
Vivek Jain Chairman and CEO |
SELL
Bona fide gift
|
Direct |
30
-0.19%
|
-
|
|
May 13
2022
|
Elisha W Finney |
SELL
Bona fide gift
|
Direct |
743
-38.44%
|
-
|
|
May 12
2022
|
George A Lopez Director |
BUY
Open market or private purchase
|
Direct |
25,835
+1.85%
|
$4,443,620
$172.99 P/Share
|
|
May 12
2022
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Open market or private sale
|
Direct |
750
-18.2%
|
$129,750
$173.56 P/Share
|
|
May 12
2022
|
Elisha W Finney |
SELL
Open market or private sale
|
Direct |
217
-10.09%
|
$36,890
$170.53 P/Share
|
|
May 11
2022
|
David C. Greenberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
433
+10.73%
|
-
|
|
May 11
2022
|
Laurie Hernandez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
352
+43.78%
|
-
|
|
May 11
2022
|
Donald Abbey |
BUY
Exercise of conversion of derivative security
|
Direct |
433
+21.36%
|
-
|
|
May 11
2022
|
David F Hoffmeister |
BUY
Exercise of conversion of derivative security
|
Direct |
433
+21.36%
|
-
|
|
May 11
2022
|
Kolleen T Kennedy |
BUY
Exercise of conversion of derivative security
|
Direct |
129
+50.0%
|
-
|
|
May 11
2022
|
Elisha W Finney |
BUY
Exercise of conversion of derivative security
|
Direct |
433
+16.76%
|
-
|
|
Mar 08
2022
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,163
-17.52%
|
-
|
|
Mar 08
2022
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,209
+24.96%
|
-
|
|
Mar 08
2022
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,328
-7.89%
|
-
|
|
Mar 08
2022
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,524
+13.04%
|
-
|
|
Mar 08
2022
|
Kevin J Mc Grody Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
841
+14.79%
|
-
|
|
Mar 08
2022
|
Kevin J Mc Grody Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
442
-9.94%
|
-
|
|
Mar 08
2022
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,196
-22.49%
|
-
|
|
Mar 08
2022
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,272
+29.94%
|
-
|
|
Mar 08
2022
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
894
-7.59%
|
-
|
|
Mar 08
2022
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,020
+14.64%
|
-
|
|
Mar 08
2022
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,163
-7.92%
|
-
|
|
Mar 08
2022
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,209
+13.08%
|
-
|
|
Mar 06
2022
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,196
-12.44%
|
$289,432
$242.93 P/Share
|
|
Mar 06
2022
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,273
+18.93%
|
-
|
|
Mar 06
2022
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,692
-5.73%
|
$409,464
$242.93 P/Share
|
|
Mar 06
2022
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,216
+9.8%
|
-
|
|
Mar 06
2022
|
Kevin J Mc Grody Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
998
-10.58%
|
$241,516
$242.93 P/Share
|
|
Mar 06
2022
|
Kevin J Mc Grody Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,897
+16.71%
|
-
|
|
Mar 06
2022
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,599
-23.26%
|
$386,958
$242.93 P/Share
|
|
Mar 06
2022
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,039
+30.63%
|
-
|